Electroporation of polymeric nanoparticles: An alternative technique for transdermal delivery of insulin

Drug Development and Industrial Pharmacy

Volumn 36, Issue 11, 2010, Pages 1303-1311

  Rastogi, Rachna ^a,b   Anand, Sneh ^a,b   Koul, Veena ^a,b  

^a INDIAN INSTITUTE OF TECHNOLOGY DELHI   (India)

^b ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Electroporation; In vitro and in vivo evaluation; Insulin; Nanoparticles; Transdermal

Indexed keywords

GLUCOSE; MACROGOL; POLYCAPROLACTONE; RECOMBINANT HUMAN INSULIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG PENETRATION; ELECTROPORATION; GLUCOSE BLOOD LEVEL; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; MALE; NONHUMAN; RAT; STREPTOZOCIN DIABETES;

ADMINISTRATION, CUTANEOUS; ANIMALS; BLOOD GLUCOSE; DIABETES MELLITUS, EXPERIMENTAL; DRUG CARRIERS; ELECTROPORATION; HYPOGLYCEMIC AGENTS; INSULIN; MALE; MICROSCOPY, CONFOCAL; NANOPARTICLES; POLYMERS; RATS; RATS, WISTAR; SKIN ABSORPTION; STREPTOZOCIN;

EID: 77956909279     PISSN: 03639045     EISSN: 15205762     Source Type: Journal    
DOI: 10.3109/03639041003786193     Document Type: Article

References (39)

1. Barry BW, Williams AC. (1995). Permeation enhancement through skin. In: Swarbrick J, Boylan JC, eds. Encyclopaedia of pharmaceutical technology, vol.11. New York: Marcel Dekker, 449-493
2. Barry BW. (2001). Novel mechanisms and devices to enable successful transdermal drug delivery. Eur J Pharm Sci, 14:101-114
3. Dixit N, Bali V, Baboota S, Ahuja A, Ali J. (2007). Iontophoresis-an approach for controlled drug delivery: A review. Curr Drug Deliv, 4:1-10.
4. Gonzalez C, Kanevsky D, De Marco R, Di Girolamo G, Santoro S. (2006). Non-invasive routes for insulin administration: Current state and perspectives. Expert Opin Drug Deliv, 3:763-770
5. Khafagy ES, Morishita M, Onuki Y, Takayama K. (2007). Current challenges in non invasive insulin delivery systems: A comparative review. Adv Drug Deliv Rev, 59:1521-1546
6. Li YZ, Quan YS, Zang L, Jin MN, Kamiyama F, Katsumi H, et al. (2009). Trypsin as a novel potential absorption enhancer for improving the transdermal delivery of macromolecules. J Pharm Pharmacol, 61:1005-1012
7. Li YZ, Quan YS, Zang L, Jin MN, Kamiyama F, Katsumi H, et al. (2008). Transdermal delivery of insulin using trypsin as a biochemical enhancer. Biol Pharm Bull, 31:1574-1579
8. Prausnitz MR. (2004). Microneedles for transdermal drug delivery. Adv Drug Deliv Rev, 56:581-587
9. Prausnitz MR, Langer R. (2008). Transdermal drug delivery. Nat Biotechnol, 26:1261-1268
10. Rao R, Nanda S. (2009). Sonophoresis: Recent advancements and future trends. J Pharm Pharmacol, 61:689-705.
11. Sadrzadeh N, Glembourtt MJ, Stevenson CL. (2007). Peptide drug delivery strategies for the treatment of diabetes. J Pharm Sci, 96:1925-1954
12. Shaikh IM, Jadhav KR, Ganga S, Kadam VJ, Pisal SS. (2005). Advanced approaches in insulin delivery. Curr Pharm Biotechnol, 6:387-395
13. Sintov AC, Wormser U. (2007). Topical iodine facilitates transdermal delivery of insulin. J Control Release, 118:185-188
14. Elsayed MMA, Abdallah OY, Naggar VF, Khalafallah NM. (2007). Lipid vesicles for skin delivery of drugs: Reviewing three decades of research. Int J Pharm, 332:1-16.
15. Torchilin VP. (2007). Micellar nanocarriers: Pharmaceutical perspectives. Pharm Res, 24:1-16.
16. Antonietti M, Forster S. (2003). Vesicles and liposomes: A self assembly principle beyond lipids. Adv Mater, 15:1323-1333
17. Rastogi R, Anand S, Koul V. (2009). Polymerosomes of PCL and PEG demonstrate enhanced therapeutic efficacy of insulin. Curr Nanosci, 5:409-416
18. Chen H, Zhu H, Zheng J, Mou D, Wan J, Zhang J, et al. (2009). Iontophoresis-driven penetration of nanovesicles through microneedle-induced skin microchannels for enhancing transdermal delivery of insulin. J Control Release, 139: 63-72, doi:10.1016/j.jconrel.2009.05.031.
19. Kim MS, Seo KS, Khang G, Cho SH, Lee HB. (2004). Preparation of poly(ethylene glycol)-block-poly(caprolactone) copolymers and their applications as thermo-sensitive materials. J Biomed Mater Res A, 70:154-158
20. Rastogi R, Anand S, Koul V. (2009). Flexible polymerosomes-An alternative vehicle for topical delivery. Colloids Surf B Biointerfaces, 72:161-166
21. Kligman AM, Christophers E. (1963). Preparation of isolated sheets of human stratum corneum. Arch Dermatol, 88:702-705
22. Junod A, Lambert AE, Stauffacher W, Renold AE. (1969). Diabetogenic action of streptozotocin: Relationship of dose to metabolic response. J Clin Invest, 48:2129-2139
23. Badkar AV, Betageri GV, Hofmann GA, Banga AK. (1999). Enhancement of transdermal iontophoretic delivery of a liposomal formulation of colchicines by electroporation. J Drug Deliv, 6:111-115
24. Essa EA, Bonner MC, Barry BW. (2002). Iontophoretic estradiol skin delivery and tritium exchange in ultradeformable liposomes. Int J Pharm, 240:55-66.
25. Essa EA, Bonner MC, Barry BW. (2003). Electroporation and ultradeformable liposomes; human skin barrier repair by phospholipids. J Control Release, 92:163-172
26. Essa EA, Bonner MC, Barry BW. (2004). Electrically assisted skin delivery of liposomal estradiol; phospholipid as damage retardant. J Control Release, 95:535-546
27. Kigasawa K, Kajimoto K, Watanabe M, Kanamura K, Saito A, Kogure K. (2009). In vivo transdermal delivery of diclofenac by ion-exchange iontophoresis with geraniol. Biol Pharm Bull, 32:684-687
28. Shakeel F, Ramadan W, Ahmed MA. (2009). Investigation of true nanoemulsions for transdermal potential of indomethacin: Characterization, rheological characteristics, and ex vivo skin permeation studies. J Drug Target, 17:435-441
29. Takmaz EA, Inal O, Baykara T. (2009). Studies on transdermal delivery enhancement of zidovudine. AAPS PharmSciTech, 10:88-97.
30. Sharma A, Kara M, Smith FR, Krishnan TR. (2000). Transdermal drug delivery using electroporation. I. Factors influencing in vitro delivery of terazosin hydrochloride in hairless rats. J Pharm Sci, 89:528-535
31. Medi BM, Singh J. (2003). Electronically facilitated transdermal delivery of human parathyroid hormone (1-34). Int J Pharm, 263:25-33.
32. Martin GT, Pliquett UF, Weaver JC. (2002). Theoretical analysis of localized heating in human skin subjected to high voltage pulses. Bioelectrochemistry, 57:55-64.
33. Pliquett UF, Martin GT, Weaver JC. (2002). Kinetics of the temperature rise within human stratum corneum during electroporation and pulsed high-voltage iontophoresis. Bioelectrochemistry, 57:65-72.
34. Jadoul A, Preat V. (1997). Electrically enhanced transdermal delivery of domperidone. Int J Pharm, 154:229-234
35. Prausnitz MR, Lee CS, Liu CH, Pang JC, Singh T, Langer R, et al. (1996). Transdermal transport efficiency during skin electroporation and iontophoresis. J Control Release, 38:205-217
36. Vanbever R, Pliquett UF, Preat V, Weaver JC. (1999). Comparison of the effects of short, high-voltage and long, medium-voltage pulses on skin electrical and transport properties. J Control Release, 69:35-47.
37. Sung KC, Fang JY, Wang JJ, Hu OYP. (2003). Transdermal delivery of nalbuphine and its prodrugs by electroporation. Eur J Pharm Sci, 18:63-70.
38. Freeman SA, Wang MA, Weaver JC. (1994). Theory of electroporation of planar bilayer membranes: Predictions of the aqueous area, change in capacitance, and pore-pore separation. Biophys J, 67:42-56.
39. Medi BM, Singh J. (2006). Skin targeted DNA vaccine delivery using electroporation in rabbits II. Safety. Int J Pharm, 308:61-68